{"id":"https://openalex.org/W4210508331","doi":"https://doi.org/10.1002/jac5.1607","title":"Four models of pharmacist\u2010integrated office\u2010based opioid treatment","display_name":"Four models of pharmacist\u2010integrated office\u2010based opioid treatment","publication_year":2022,"publication_date":"2022-01-30","ids":{"openalex":"https://openalex.org/W4210508331","doi":"https://doi.org/10.1002/jac5.1607"},"language":"en","primary_location":{"id":"doi:10.1002/jac5.1607","doi":"https://doi.org/10.1002/jac5.1607","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jac5.1607","pdf_url":null,"source":{"id":"https://openalex.org/S4210206892","display_name":"JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY","issn_l":"2574-9870","issn":["2574-9870"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","medline","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032449944","display_name":"Olivia Caron","orcid":"https://orcid.org/0000-0002-8315-8908","observed_orcids":["https://orcid.org/0000-0002-8315-8908"]},"institutions":[{"id":"https://openalex.org/I4210124200","display_name":"Mountain Area Health Education Center","ror":"https://ror.org/031vnay14","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210124200"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Olivia Caron","raw_affiliation_strings":["Mountain Area Health Education Center (MAHEC) Family Health Center, Asheville, North Carolina, USA"],"raw_orcid":"https://orcid.org/0000-0002-8315-8908","affiliations":[{"raw_affiliation_string":"Mountain Area Health Education Center (MAHEC) Family Health Center, Asheville, North Carolina, USA","institution_ids":["https://openalex.org/I4210124200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067953098","display_name":"Allison E. Fay","orcid":"https://orcid.org/0000-0001-8870-2709","observed_orcids":["https://orcid.org/0000-0001-8870-2709"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allison E. Fay","raw_affiliation_strings":["The Family Health Centers, Asheville, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Family Health Centers, Asheville, North Carolina, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019191689","display_name":"Haley Pressley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haley Pressley","raw_affiliation_strings":["University of North Carolina (UNC) Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina (UNC) Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088531855","display_name":"Gwen Seamon","orcid":"https://orcid.org/0000-0001-8535-7292","observed_orcids":["https://orcid.org/0000-0001-8535-7292"]},"institutions":[{"id":"https://openalex.org/I4210124200","display_name":"Mountain Area Health Education Center","ror":"https://ror.org/031vnay14","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210124200"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gwen Seamon","raw_affiliation_strings":["MAHEC Family Health Center, Asheville, North Carolina, USA"],"raw_orcid":"https://orcid.org/0000-0001-8535-7292","affiliations":[{"raw_affiliation_string":"MAHEC Family Health Center, Asheville, North Carolina, USA","institution_ids":["https://openalex.org/I4210124200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078106776","display_name":"Shawn Riser Taylor","orcid":"https://orcid.org/0000-0002-6689-3820","observed_orcids":["https://orcid.org/0000-0002-6689-3820"]},"institutions":[{"id":"https://openalex.org/I148244530","display_name":"Wingate University","ror":"https://ror.org/01yyxv878","country_code":"US","type":"education","lineage":["https://openalex.org/I148244530"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shawn Riser Taylor","raw_affiliation_strings":["Wingate University School of Pharmacy, Hendersonville, North Carolina, USA"],"raw_orcid":"https://orcid.org/0000-0002-6689-3820","affiliations":[{"raw_affiliation_string":"Wingate University School of Pharmacy, Hendersonville, North Carolina, USA","institution_ids":["https://openalex.org/I148244530"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059430832","display_name":"Courtenay Gilmore Wilson","orcid":"https://orcid.org/0000-0002-4634-7013","observed_orcids":["https://orcid.org/0000-0002-4634-7013"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4210124200","display_name":"Mountain Area Health Education Center","ror":"https://ror.org/031vnay14","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210124200"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtenay Gilmore Wilson","raw_affiliation_strings":["Department of Family Medicine, Mountain Area Health Education Center (MAHEC), Asheville, North Carolina, USA","Department of Research, UNC Health Sciences at MAHEC, Asheville, North Carolina, USA","Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA"],"raw_orcid":"https://orcid.org/0000-0002-4634-7013","affiliations":[{"raw_affiliation_string":"Department of Family Medicine, Mountain Area Health Education Center (MAHEC), Asheville, North Carolina, USA","institution_ids":["https://openalex.org/I4210124200"]},{"raw_affiliation_string":"Department of Research, UNC Health Sciences at MAHEC, Asheville, North Carolina, USA","institution_ids":["https://openalex.org/I4210124200"]},{"raw_affiliation_string":"Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5032449944"],"corresponding_institution_ids":["https://openalex.org/I4210124200"],"apc_list":{"value":3050,"currency":"USD","value_usd":3050},"apc_paid":null,"fwci":1.2025,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.75079156,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"5","issue":"4","first_page":"413","last_page":"421"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/office-based-opioid-treatment","display_name":"office-based opioid treatment","score":0.8259999752044678},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.847000002861023},{"id":"https://openalex.org/keywords/role-of-pharmacists","display_name":"pharmacist role","score":0.7870000004768372},{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.8209999799728394},{"id":"https://openalex.org/keywords/pharmacist-prescribing","display_name":"pharmacist prescribing","score":0.39500001072883606},{"id":"https://openalex.org/keywords/pharmacy-education","display_name":"pharmacy education","score":0.5329999923706055},{"id":"https://openalex.org/keywords/implementation-barriers","display_name":"implementation barriers","score":0.7879999876022339},{"id":"https://openalex.org/keywords/naloxone-access","display_name":"naloxone access","score":0.7009999752044678},{"id":"https://openalex.org/keywords/federally-qualified-health-centers","display_name":"federally qualified health centers","score":0.7080000042915344},{"id":"https://openalex.org/keywords/family-medicine-residency","display_name":"family medicine residency","score":0.7210000157356262},{"id":"https://openalex.org/keywords/community-pharmacy","display_name":"community pharmacy","score":0.4259999990463257}],"concepts":[{"id":"https://openalex.org/C2779457091","wikidata":"https://www.wikidata.org/wiki/Q105186","display_name":"Pharmacist","level":3,"score":0.8906596899032593},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.73420250415802},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.6868922710418701},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.6303609609603882},{"id":"https://openalex.org/C2777543875","wikidata":"https://www.wikidata.org/wiki/Q797551","display_name":"Waiver","level":2,"score":0.6193395256996155},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.6006036400794983},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.5235702395439148},{"id":"https://openalex.org/C10446079","wikidata":"https://www.wikidata.org/wiki/Q155491","display_name":"Clinical pharmacy","level":3,"score":0.518793523311615},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.5146868824958801},{"id":"https://openalex.org/C2780670349","wikidata":"https://www.wikidata.org/wiki/Q12061588","display_name":"Medication therapy management","level":4,"score":0.44608867168426514},{"id":"https://openalex.org/C3019612716","wikidata":"https://www.wikidata.org/wiki/Q730920","display_name":"Problem solver","level":2,"score":0.44585657119750977},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.39751648902893066},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.18669629096984863},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08152532577514648},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C126255220","wikidata":"https://www.wikidata.org/wiki/Q141495","display_name":"Mathematical optimization","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/jac5.1607","doi":"https://doi.org/10.1002/jac5.1607","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jac5.1607","pdf_url":null,"source":{"id":"https://openalex.org/S4210206892","display_name":"JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY","issn_l":"2574-9870","issn":["2574-9870"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","medline","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W157157778","https://openalex.org/W1770934634","https://openalex.org/W2004164766","https://openalex.org/W2030329606","https://openalex.org/W2591231454","https://openalex.org/W2594235882","https://openalex.org/W2626373776","https://openalex.org/W2765903045","https://openalex.org/W2766969415","https://openalex.org/W2768214444","https://openalex.org/W2782433140","https://openalex.org/W2808907017","https://openalex.org/W2811048453","https://openalex.org/W2899559156","https://openalex.org/W2955994854","https://openalex.org/W2991474708","https://openalex.org/W3005451454","https://openalex.org/W3090428510","https://openalex.org/W3097261262","https://openalex.org/W3116478769","https://openalex.org/W3132761476","https://openalex.org/W3157361215","https://openalex.org/W3205115907","https://openalex.org/W4239770003"],"related_works":["https://openalex.org/W4200061925","https://openalex.org/W4396803046","https://openalex.org/W3119512592","https://openalex.org/W1521070935","https://openalex.org/W3119890237","https://openalex.org/W2754030158","https://openalex.org/W4404485636","https://openalex.org/W7004936753","https://openalex.org/W7061779309","https://openalex.org/W4387709696"],"abstract_inverted_index":{"Abstract":[0],"Purpose":[1],"In":[2,165],"2019,":[3],"one":[4,81],"point":[5],"six":[6],"million":[7],"Americans":[8],"had":[9],"opioid":[10,26],"use":[11],"disorder":[12],"(OUD),":[13],"yet":[14],"only":[15],"18%":[16],"of":[17,32,52,61,73,112,124,167,244,269],"those":[18],"patients":[19,185],"received":[20],"treatment":[21,27],"with":[22,36,43],"evidence\u2010based":[23],"medications.":[24],"Office\u2010based":[25],"(OBOT)":[28],"is":[29],"the":[30,110,129,133,136,158,223,266,270],"provision":[31],"care":[33,192,202],"for":[34,57,210,278],"OUD":[35,216,231,273],"buprenorphine,":[37],"in":[38,80,89,217,232],"various":[39],"formulations":[40],"including":[41],"combination":[42],"naloxone,":[44],"and":[45,71,101,126,143,178,186,199,203,234,248,276],"naltrexone.":[46],"Currently,":[47],"there":[48],"are":[49],"few":[50],"reports":[51],"physician\u2010pharmacist":[53],"collaborative":[54],"practice":[55],"models":[56,114],"OBOT.":[58],"The":[59],"purpose":[60],"this":[62],"study":[63],"was":[64],"to":[65,145,152,250],"identify":[66],"common":[67],"roles,":[68],"clinical":[69],"backgrounds,":[70],"barriers":[72,144],"pharmacists":[74,85,131,171,183,195,213,221,228,236,279],"within":[75],"four":[76,130,200],"pharmacist\u2010integrated":[77],"OBOT":[78,87,113,141,197,206,260],"services":[79,88],"community.":[82],"Methods":[83],"Four":[84],"implemented":[86],"a":[90,97,102,120],"family":[91],"medicine":[92],"(FM)":[93],"residency,":[94,96,233],"obstetrics\u2010gynecology":[95],"physician\u2010owned":[98],"FM":[99],"practice,":[100],"Federally":[103],"Qualified":[104],"Health":[105],"Center.":[106],"Each":[107],"pharmacist":[108,149],"detailed":[109],"evolution":[111],"at":[115],"their":[116],"respective":[117],"sites.":[118],"Using":[119],"21\u2010item":[121],"questionnaire":[122],"comprised":[123],"closed":[125],"open\u2010ended":[127],"questions,":[128],"describe:":[132],"setting's":[134],"OBOT;":[135],"pharmacist's":[137],"OUD\u2010related":[138],"training;":[139],"pharmacist\u2010related":[140],"activities;":[142],"implementation.":[146],"Results":[147],"One":[148],"spends":[150],"10":[151,163],"20":[153],"h/wk":[154],"on":[155,205],"OBOT,":[156],"while":[157],"others":[159],"spend":[160],"less":[161],"than":[162],"h.":[164],"terms":[166],"patient":[168],"care,":[169],"two":[170,212,220,227],"conducted":[172,187],"intake,":[173],"group":[174],"visits,":[175],"collected":[176],"vitals,":[177],"ensured":[179],"naloxone":[180],"access.":[181],"All":[182],"counseled":[184],"follow\u2010up":[188],"visits.":[189],"For":[190],"nonpatient":[191],"activities,":[193],"three":[194,235],"developed":[196],"policies/procedures,":[198],"coordinated":[201],"consulted":[204],"cases.":[207],"To":[208],"prepare":[209],"this,":[211],"learned":[214,229],"about":[215,230],"pharmacy":[218,274],"school,":[219],"completed":[222],"buprenorphine":[224],"waiver\u2010training":[225],"course,":[226],"attended":[237],"continuing":[238],"education.":[239],"Barriers":[240],"identified":[241],"were":[242],"lack":[243],"designated":[245],"time,":[246],"funding,":[247],"ability":[249],"prescribe":[251],"buprenorphine.":[252],"Conclusion":[253],"Pharmacists":[254],"can":[255],"effectively":[256],"integrate":[257],"into":[258],"many":[259],"settings.":[261],"Future":[262],"work":[263],"should":[264],"standardize":[265],"optimal":[267],"role":[268],"pharmacist,":[271],"expand":[272],"education,":[275],"advocate":[277],"as":[280],"waivered":[281],"providers.":[282]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-02-08T00:00:00"}